While CD28 expression on microglia correlated with more favorable outcomes and NC-GBM tumors (Supplemental Figure 11P), CD38, CCR4, TIM3, and CD57 were associated with worse outcomes (Supplemental Figure 11, Q–T). The gene discussed is HAVCR2; the disease is glioblastoma.